← FDA Drug Approvals (Drugs@FDA)
SITAGLIPTIN PHOSPHATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2026-02-23
Drug application
- FDA Application #
ANDA215155- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SITAGLIPTIN PHOSPHATE
- Generic name
- Sitagliptin Phosphate
- Active ingredients
- SITAGLIPTIN PHOSPHATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- ALKEM LABS LTD
- First approval
- 2026-02-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown